Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Selecting Hypoxic Tumours for Treatment Modification

NCT06787053 is registered in ClinicalTrials.gov with University of Manchester as lead sponsor.

NCT NCT06787053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06787053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Selecting Hypoxic Tumours for Treatment Modification
Lead sponsor
University of Manchester
Phase
Observational
Overall status
Recruiting
Start date
October 16, 2024
Completion date
May 30, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder (urothelial, transitional cell) cancer, prostate cancer